TRANSKRIP 🔗
0:00
What made you transition from like more traditional medicine to that interest in longevity and and aging? It's an interesting question because I guess I'd never thought about it in these terms. I, I went to medical school wanting to do research. So I'm sort of one of these unusual people that did not go to medical school thinking I'm going to be a doctor. Went to medical school wanting to learn a human biology, essentially, and right up to medical school. I guess I got I got called into the game and eventually got some clinical training. So I did two years of clinical training in internal medicine. And the one in the lab at the time, you finally what I wanted to do, but I never came out of the lab, so never went back to practicing medicine. Excuse me. And, and so I've done, you know, my pretty much my whole career in in biomedical research. Always really trying to see how can what I'm learning have an impact on human health and in some way. And I've worked on a whole series of topic and worked for many years on HIV and the transcriptional regulation of HIV, the epigenetics of HIV. And through that, eventually ended up working on aging, which is something a switch that happened about 20 years ago in my lab. So in some way, aging became an incredibly interesting topic for a number of reasons why it became something that I was I was concerned about for myself, but also we had a really sort of unique outlook on how what some of the pathways that regulate aging could be doing. And so when I saw this and this, amazingly enough, came out of the work on HIV, which is just shows you are all of biology is as united and the same pathways are at work to control HIV transcription as they are to control our aging. So that's that was sort of the long winded answer of how did I end up working on aging? Wow. And it seems like even more than biology, like I get the impression that in longevity especially, it's such a multi-discipline injury area that you can get maybe insights from even from fields that you wouldn't expect right? I mean, that's the beauty of biology. You know, we've gone from a model of of biology, which was basically or medicine which was driven by 16/17 century science when the humans were first dissected and people discovered organs. And and we still have a system of medicine which is organized across these systems. You know, you go to a heart doctor, you go see a neurologist for your brain. And these doctors are treating each organ as if it were sort of a different an independent entity. Everything is incredibly integrated. And, you know, one thing that really the space of aging research has brought is what we call systems medicine, which, you know, I think aging research is really at the forefront. And that hopefully will change the way we we think about about aging and about biology. This idea that you're treating these all of these diseases, we call it Whac-A-Mole medicine, because imagine if someone comes in with a heart attack at 60, you treat the heart attack and medicine is very good at allowing you to survive an initial heart attack and you survive. You keep getting a little older. And aging by itself is the biggest risk factor for all of these diseases that we stock, that, you know, heart disease, heart attack, stroke, type two diabetes, Alzheimer's, Parkinson's, many forms of cancer, osteoporosis, macular degeneration, the list goes on and on. We're surrounded by people in our families or parents or grandparents who are actually suffering from all of those. So you have your initial heart attack that we treat. You're doing well, you survive, You go home, another two years pass. Well, the clock keeps ticking and aging being the biggest risk factor for these diseases. But next is you you get some form of cancer. And again, medicine is doing a very good job at treating the cancer. It's not really paying attention to how to prevent it. But so we treat the cancer and then you survive and the clock keeps ticking. And five years later, you develop Alzheimer's disease. And, you know, this is this is the normal course of aging for many people. And what I think the aging field is bringing is is a completely different perspective to this. Not that we're going to be eliminating all diseases or make people live forever. It's not going to happen. But this idea that by 65 you should be already ill with one disease, by 70 you should have two, which is, by the way, the case for most people today in the Western world, if you're 70 years old, you carry at least two of these chronic conditions that I told you about. Yeah. Can we change that equation? Can we help people live better longer? And I think, yes, the answer is clearly yes, even simply by lifestyle changes. So that's really what we are about. And of course, the future is to change, you know, more dramatically the way we age. But we can do this in animal models. But I'm really excited about what we can do today in humans. So how how would you like to see things change in the way we practice medicine? So I, I would love for us to do to take a much more proactive way we treat medicine. Medicine right now is mostly mostly reactive, and I know some colleagues well. I'm a physician, so I'm not here to bash medicine. So I, I was trained and I medicine has done amazing things to bring us to where we are today. You know, our lifespans are double what it was about 150 years ago. So it's an incredibly remarkable achievement. But I think we've sort of reached the limit of this model in a way that we know the first time I ask people who wants to live to 120? No one raised their hands in the audience because it's obvious that we associate for very good reason aging with disease. The question is, can we break that relationship? And the answer is yes. So by taking a much more proactive way, in a way, we look at our aging as young as possible, but it's never too late. It's the other, you know, as young as possible. That's the best. But it's
Load full transcript
never too late to change lives. You can really alter this equation that we make in our mind, which is actually real between aging and being sick and I've made the point that I think today most people could live to 95 in good health. Most people, you know, they're always going to be, of course, some people who have an unexpected disease and so on. But for the average population to live to 1995 in good health is not a pipe dream. It's a reality that we could implement today. And instead we see a shortening of lifespan, at least in the U.S. and I think probably in the rest of the Western world. So regardless of the emerging science that maybe we're going to see new therapies in the near future, you say that we already have the means to make people help people live longer, healthier with the knowledge and tools we have today. Exactly. Exactly. Totally. And yeah, the whole idea is to start early aging. You know, we we treat diseases. If there were the day they happened, they were occurrence something that happened recently. But we know that the seeds for many of these diseases were planted 15, 20 years earlier. And we know that, you know, the disease processes are very long and there are initial. Right now we're treating the disease when it when it's diagnosed. I'll give you an example. With type two diabetes, your blood sugar is above a certain level. If it's one unit below your normal, if you're one of the one unit above, you're diabetic or pre-diabetic. Well, we know that these numbers change over a long period of time. We also know that once you get to that level of having type two diabetes, the process is so ingrained, you have compensate, you have the initial lesion, then you have response from your body, then you have further progression. So it's a long completely. So you're trying to treat a system that's completely dysregulated, very virtually starting very early when you have a single modification that you can actually intervene and modify. So that's that's the vision. Can we really change the way we look at health as a as a continuum? Can we identify these early signature of abnormalities and can we treat those? Quite often we treat disease in a way that is very complicated, very aggressive when when the modifications or the abnormalities are very early, they're much easier to correct. So that's really the whole vision. A Switching to a more preventative medicine and understanding that aging and its pathway is the biggest driver of all of the disease that I mentioned before. You know, people, you know, probably know about statins know these are drugs that$20 billion a year are being sold or they started to lower cholesterol. Cholesterol, your cholesterol level is a risk factor for heart attacks. Is seven times less important than your age. And so why are we treating cholesterol better? We're not treating age basically. And so what the signs of aging is told us know is that we can I we've identified some of the key pathways that drive aging.
So why not target those if they're going to be seven times more important? That's really in some way the whole vision of what we're trying to accomplish. So just to make it clear. So right now we have some some knowledge, some tools, but longevity science is also about finding new therapies and technologies to allow us to make more of an impact on those aging pathways that cause disease. And yes, it seems like I heard you say that you feel that we're now at an inflection point and that we're now is the time to kind of transition from lab animal studies to humans. Why do you feel now is is the time? It's pretty much sure It's a historic goal sort of observation that's been made in many systems. You know, you make an initial observation that aging, for example, can be modulated by genes and drugs. This happened 20, 25 years ago. And in the models and it takes a long time first, you know, nobody believes this data. That was what happened in 1995 since again in Lenny Durante, Garry Risk and a whole group of Tom Johnson, a whole group of scientists published these papers and everybody said, yeah, it's interesting. You can find genes that regulate aging, but it's the exception. Well, turns out it's not the exception we have now. Just in the little worm C elegans close to 700 genes that actually regulate aging. So and we have drugs. We decide dozens of drugs. So I think you know and a lot of work has been done to validate these pathways. We know what the major pathways are that regulate aging. We don't have a full understanding of aging. Don't get me wrong, it's still a lot of work that needs to be done. And so my passion really is is between those two poles to continue to do the groundbreaking research that we do at the Buck and other organizations to really push our understanding of aging much deeper. And again, as I said, there's a lot that still needs to be learned, but also really realizing the potential of all these discoveries for humans. And I think that's an equally passion by both. And that's what we're trying to do at the park, really builds a whole clinical infrastructure that can it's hard. I mean, this is one thing that is a bit sometimes disconcerting for me as a physician scientist is to talk to colleagues or pure basic scientists who tell me, yeah, we've got to give this to humans. Well, it's really hard. It's hard, it's expensive, it's long. We have to be careful. The last thing that this field can afford is to actually kill some 20 year olds with some, you know, risky intervention that will that will hurt us very profoundly. So I think we have to proceed in a way that's optimistic, but we have to do it. We cannot just keep delaying and say, well, we'll do it when it's perfect. It's not perfect, but we have some really strong hints of things that we could do to really change the way people are aging. And I think what's most exciting for me is the public is really responding. You know, there's so much interest. You're here for a reason.
You probably have friends who are talking about biohacking and all of this. There's so much discussion about what's happening in the field. And frankly, sometimes we have the feeling in the research field that we are being overwhelmed by the demand. But how much people are jumping on all kinds of unproven. And, you know, I joined some biohacking, our website, just to watch. And it's fascinating for me the interest, but it's also somewhat scary to be honest, because some people are just going crazy. And I do not measure the risk of what that potentially taking. Yes, it's interesting you mention this because I actually feel very isolated with my interest in longevity and especially in the science, because I do have friends around me who of course, like by like I read of this book look like this and do podcasts about, you know, how to eat better and how to exercise better. And I got to say that, of course I understand how important it is, especially as long as we don't have better tools to maybe make those efforts obsolete. But what always concerns me a little bit is that it's it's as if this is how the public knows longevity as just like tweaking and improving and optimizing your diet and your exercise and your lifestyle. And I feel like it might be misleading that people are not aware that the promise of the science is so much more than that. It's like it could actually become like the next generation of medicine, I assume, where where we can help people so much more because I think from what I understand, no matter how perfectly we eat and exercise, we can't like completely avoid the suffering that comes with biological aging at this point. So so what what do you think about that? Because I see a lot of longevity experts, especially like very high profile longevity experts who published books. And like at the end of the day, most of the public conversation around their work is really those kinds of lifestyle things. And I wonder if it helps the field or maybe it's also a problem. I think it's a reflection of it's a good observation. It's a reflection of where we are. So the problem is so is is the difference between an association and a causation. So there is clear association with a healthy lifestyle and a long life, you know, free of disease. And and there's also evidence that about 93% of your longevity is determined by lifestyle factors, only about 7% by genetics. So you can't we're not going to change genomes for a long time. My prediction to modify aging, although they might be that we already changing not the genome, but we're using gene therapy for vaccines and so on. So I think I could certainly see a day that this would come before aging as well. But let me say, how do I put this? The problem is that all of the information that we have is based on association. And we know that if you exercise, you're going to live longer. But we aggregate exercise, you know, by studying thousands of people and looking, you know, who is exercising or not. What we don't know, for example, is what form of exercise, how much of what's best for you, not for your neighbor. And so there's there's a real need. And the same goes for everything. Nutrition. We know people eventually live longer than people, you know, who don't eat vegetables. We know people who do. So not in Finland. The more they do it, the less they have Alzheimer's cancers, type two, diabetes and so on. So all these studies exist, but they're not causative. They're not true. They just association. We also know, for example, that if you're floss your teeth, you live on average three years longer than somebody who doesn't floss their teeth. I don't think anybody really thinks that flossing the teeth is making you live longer. It's just a reflection of of your lifestyle. And so we're at this stage where we have a whole series of of observations that tells us that the people who live longer tend to be looking like this, their philosophy, their watch, what they eat to exercise, they go to sleep, they sleep well, they don't drink too much alcohol, blah, blah, blah. What's really missing is what are the biggest variables out of all of those? Can we actually identify them for each person? How will you? And I said, This is the whole idea of biomarkers. You know, can we measure you at age 30 and determine what are your risk factors and introduce some sort of measured interventions? Right now we have what I call the crazy young girl. I have 30 year old people coming and seeing me and saying, I want to be on metformin. I said, Why do you want to go on metformin? Well, it's an anti-aging drug. I said, Well, not so far. Do you realize that metformin is going to suppress your testosterone? no, I never thought about this. Okay. You're 30 years old. You know, you don't want to do this period unless you are a very high risk of getting type two diabetes. So right now, people are hearing things happening. And in research and they're you know, they do not they first, the infrastructure for delivering this type of medicine is just being built with all of these longevity clinics. And even within the longevity clinics I work with, many of them, we're learning we don't know how to do deliver longevity medicine. So there's a whole process. I think that's going to happen in the next, I predict, 10 to 20 years of really understand how do we actually really do a true preventative medicine that's based on biology. That's where we are in the field. So, you know, a lot of people take the situation in their own hands and they'll take the supplement. That supplement that I always I do take supplements, too. I take people you know, I tell people it's it's it's a bit of a gamble. You're taking a chance based on the animal research, but there's no proof that it will do anything and it might actually hurt you. So always trying to find that balance of where, you know, what you described earlier in your question is a reflection of where the field is. We're taking baby
steps in the direction of a true preventative medicine. So that that person who wanted to take metformin and like this is my this is what I kind of am confused about, because it seems like it's almost like a field that is split into two disciplines. There is like, yes, the prevention and but then there is the research for the research in the hopes to find a better, better medicine. So if that person is so focused on what they can do individually to optimize their health, wouldn't we want them to be motivated to support the science by maybe, you know, putting pressure on their representatives and maybe getting involved and maybe supporting financially or using their talent to to work in the field in that. That's what I wonder about because I know that in the longevity community there is a lot of talk about how there there is a lack of funding still very much like lack of funding is one of the major bottlenecks maybe for the one. But if the if the people it speaks to think that all like the best thing they can do is to take care of their individual health and dose small ways that we don't even fully know work yet again. Aren't we missing the bigger potential of what the public can do to make longevity science more relevant, more funded and accelerated? Absolutely. All of this is actually happening. So, you know, as a as a burgeoning field, lobbying organizations are being built, clinics are being built. And so we're seeing, you know, a lot of these efforts are happening. We're organizing ourselves as scientists. We just formed a biomarker, a consortium that brings some of the best people in the field working on biomarkers. So it is, but everybody's impatient. You know, everybody wants something now. And and I think I've argued that we are at the beginning of something that's going to be enormous. I'm convinced about this based on what we've seen in our in our basic animals. And I think there's, of course, need for more funding. There's need for more support, there's need for more interest. I see this, frankly, and the amount of podcast and documentaries, all of this press that is being generated in the field, that's really good news because along with this will come education and along with the education will come to realization. There's a potential there that are, you know, elected officials could help us realize by giving more funding. So we see a lot of signs that are all going in the right direction. What's sometimes frustrating is, is this to realize that there's already a lot of knowledge that could change human health today and the feeling that many you know, I used to say that we had to change medicine. I don't think this is necessary. We're not we don't need to change medicine. Medicine is very good at what it's doing, which is to treat you when you're sick. I think we need to end to invent a new form of medicine, which is really focused on preventing you from being sick in the first place. And, you know, I went to medical school in 1980 to graduate in 1982, and we did not have a single class of words over seven years of medical school. This was a seven year program. We did not hear a word about sleep, nutrition, physical activity or stress. None of those just. And so I thought, well, this is horrible. You know, we're missing all of the important things that actually contribute to health. And I talked to friends who graduated or colleagues that graduated five or ten years ago. They told me, yeah, I had a I had to go to classes about nutrition. And so, you know, we find we've given up as a physician. And I really believe our our mission, our you know, the mission of mission of a physician in life is to keep people healthy more than to treat them. So we've given up our, you know, our authority on our ability to influence people's health by really not paying attention. And I think I'm determined now that we have these incredible tools to really try to change that equation. And I found an incredible community of likeminded physicians who are all interested in doing the same thing. That's great. I definitely know that I struggle to find medical doctors who I can. I really feel, they say, see the full picture, and that they care if I tell them that something deteriorates. They don't necessarily have to wait until it's a catastrophe to look at it more deeply. You mentioned that there already have been breakthroughs with animal studies and that you see that amazing things are going to happen. Can you share some like maybe an example of such a breakthrough that seems promising to you? Well, there are so many, frankly, at this point. I'll give you the example of calorie restriction, which is a really good story because it started actually 100 years ago. And you we would all hope that the translation of basic research to humans would go faster than this. But it's a reflection of how sometimes radically new ideas take a long time to percolate. So calorie restriction is the idea. If you take an animal about living in a lab setting and you you give it you allowed it to eat as much as it wants, it will eat a certain amount, three or four grams per day. You can then do what we call calorie restriction is you cut down the amount of calories that you give to this mouse by 20% or 30% or 40% without without malnutrition. So you make sure there's enough vitamins in all of this. And what's been shown is that the more you calorie restrict them up to a certain point, of course you don't want to starve them, but they live longer, up to 30 to 40%. It remains to this day, you know, even though it's 100 so 70 to 100 years old observation, it remains the best intervention that we have against aging. We haven't been able to do anything better than this. And so the question is, how does this work? And this has led in some way to a whole field that we call calorie restriction metrics. Obviously, calorie restriction is very hard to do. And to humans, especially, someone said that it might not make you live
forever, but it will certainly feel that way, which I think you know, And so that's one way to go. But the other way is this what we call these calorie restriction metrics. These are drugs that you are taking that trigger the same type of response, because there's been a lot of effort trying to understand what happens to the physiology of your body when you are calorie restricting. And what my lab has been studying over the last 20 years is epigenetic mechanisms that are sensing the environment and trends, juicing your response and changing gene expression and really actually delaying aging. And so I'm fascinated by understanding what is it about nutrition or fasting, which is another form of nutrition that really is able to activate or regulate or modulates all of these aging pathways. So, you know, out of this came a whole series of discoveries of drugs that are acting as calorie restriction metrics. And I'll give you two example that I'm sure you've heard about metformin and rapamycin. So these are two drugs that trigger some of the same molecules that are activated during fasting. And lo and behold, you can take them while you're eating and your body still has the feeling that you are fasting. And so no big potential there for us to actually apply these drugs to humans and to do clinical trials and try to see can we really make people live longer? Can we uncouple this link between disease and aging? And so, yes, if I had to really say something that's going to be, for me, exciting in the next five years is the ability to take these existing drugs there in the clinic so you can actually give them to people and to test you see how does it change the way people are aging? So for long living animals like us, it's it sounds to me that even like mimicking fasting or calorie restriction is even better because then you don't risk like losing bone mass and muscle mass. And yeah, you made a statement that I think is very important, long living animals like us because, you know, everybody focuses on the naked mole rat and, you know, and these other models that are supposedly living longer. We live very long. We almost live longer than almost every animal. And based on our size, we should live much shorter, which means that, you know, this is one reason why I think humans are already, as a species, already optimized to live quite long. And so, you know, the question is, you know, that I get asked all the time is how long can we live on? Some of my colleagues go around telling, you know, I'm going to say 150, some others, you know, up the ante. I'm going to answer to 180. Well, there's no evidence for this whatsoever. Zero. And so when you are hearing these types of statement, I tell people, you know, try to understand what is that person trying to sell you? And, you know, and most of the time just selling your hope. So not data. So I'm more of a person that's really focused on what can we do now? And I think we can do amazing things if the whole population in the US would live to 95 in good health. This would be more transformative, transformational than anything we can imagine. That happens also financially, socially. At every level. Every level. Yeah. And remember that right now in the US, lifespan is actually decreasing. Really And well, yes, it's gone down from 77 to 75 and we are lagging most of the Western world by 3 to 5 years. Now which is you know, the question is why can it be reverted. And so this is sort of global population effect. And we also see something else which is that, you know, which is of concern to me in the aging field is we see a splitting of the population, you know, the wealthy, the affluent, the educated live longer and longer and the people we do not have the benefit of all of this living shorter and shorter. Right. So and it's it's interesting. I live in Spain now and it's I think it's one of the longest living countries. And, you know, they smoke and they eat a lot of fried food and it's like it's just and they also eat all day long. It's like from eight in the morning until 11 at night. And somehow, you know, it's interesting how it because in the US it seems like people are more health conscious like maybe it's not it depends where but it's it's definitely it seems like there are other factors as well. I think you mentioned it also often in your talks about for example like meaningful connections, community, things that help us. That's the number one. Yeah, that's the number one factor. Paradoxically enough, you know, loneliness is is is a credible risk factor for early deaths and human connection is the biggest predictor of your long lifespan today. But what I tell people, you know, because you might say I thought that the aging field was preoccupying itself with new biology and new drugs. And it's true. The point that I'm making is not that I don't believe these drugs or interventions are going to be available in the next few years. It's just that it's going to take us five to 10 to 20 years to get there. And today there is an incredibly powerful set of interventions that you can already do that will have that will allow you to benefit from those in the future. That's really, you know, how I look at all this. Do everything you can today so that when we come up with these things, you will be ready and available and in the best shape possible. I completely relate to that. But and you mentioned supplements that you take. Would you like to share what what those are what what you believe may be helpful or is that an individual thing? Yes, I think so. I usually do not share the supplements that I personally take because in some way, you know, the way I do it is I think the way you should do it. You should do it with the support of a physician and you should measure in your blood. So there are, you know, today a number of physicians and clinics that will help you to navigate this whole process. So first, there are individual variability. You know, I was
vitamin D deficient and vitamin B12 deficiency. If your numbers are correct, there's no reason you should take a vitamin D of B12. So these are two that I would say most people should really look at with their physician. I can tell you also there's some other supplements that I think everyone pretty much could take. Omega fatty acids. Clearly, I've been shown to be protective against heart disease. Most of us in the Western world, unless you are in Japan, are deficient and not eating enough fish, not enough fatty acid, omega fatty acids. So that's an easy way to supplement. But also again, there are ways in which you can measure in your blood whether you have a good level of omega fatty acid if you're a heavy exerciser. Creatine is something that many people in the, you know, who do sports will take. And then there's a whole slew of interventions that are that are coming up from the fields ketone body esters that I work on know I take them because I invented them. So I'm biased. And in terms of what what I think they're doing to myself, but permitting, you're releasing a let me see what the list the list goes on. And now there are so many of those that are available. What I think I really wish people would understand is that none of those are proven. And so you are always gambling in some way and some are more dangerous than others. Obviously, you know, going on rapamycin is a more significant decision. If you're a 30 year old and taking sperm today, for example. So and this is why I think even though I'm enthusiastic about the biohacking movement, I am also concerned about the biohacking movement for me as a sort of a self empowered way that people are really taking their health into their hands and they want to be taking a very proactive role. So I'm excited about the whole philosophy of it. Sometimes when I'm visiting these sites and looking at what people are doing, frankly, I get scared. I'm thinking, you know, some of these people are crazy, they doing this that are really potentially dangerous and, you know, and sometimes, you know, the thing about biology, you can do something for ten years and feel good and ten years down the line, you'll find you get a cancer that you would not have gotten. So as we think about aging, it's a long process in humans. I would encourage everyone to sort of, you know, just try to focus on the tried and true method, which is clinical trials demonstrating safety and really, you know, doing this around it, but just completely self-exploration. I think there's there's there's clearest studies. Right. And maybe I think a lot of people may be would love to find a practitioner who can help them navigate this, but nobody knows who to trust and whether there is some kind of a data base or something that where people can find someone in their area. Do you know of such a thing or such an initiative to put together a community of doctors who are willing to do this kind of work? What we are, we are talking internally. We
organize that actually at the Buck Institute, a meeting, bringing all of these longevity clinics, something I did with my colleague Joanna Burns, who has a longevity clinic in Switzerland. And then and Poland. And so we held the first meeting last year and we're going to have the second one this coming December. So this is meeting for professional physicians who are in the longevity space, but we're doing exactly what you describe. How do we how do people navigate this? You know, there's there's anti-aging medicine, which is a term that we don't like because it is generally been sort of doing things that are unproven and somewhat risky, like stem cell injections and so on. It's also linked very strongly to cosmetic medicine, which is not what this is. So, you know, how do we define a whole new field of medicine for for it to be taken seriously, for it to be reimbursed? These are all the questions that we're dealing with. And I would tell people, you know, just do your homework, explore. We will come with some better way of recommending, you know, having a society, for example, that would some form of accreditation, including, you know, that we recognize a clinic is conducting sort of state of the art. What's gold is longevity medicine, but we're not there yet. I wonder, what do you feel about you? Probably I don't know if you want to dissolve Italia now there is the initiative of Vitalism with kind of a vision for my understanding to create almost like cities that are with the community of like minded people when it comes to your health and lifestyle, What what do you think about that kind of movement? it scares me, really, because I know exactly what happens at some of those. I think the intent is right. I and I know some physicians have gone to this, but there's a lot of what I was describing earlier, sort of a promise, unrealized promise. No, you know, not understanding the risk. I, I, I love the I love the movement. And I really cannot speak to all of the details. But I know some people, some of my colleagues who have been to this told me there was no distinction between what was real and what was crazy, basically. Right. So I don't want to I don't want to sort of diminish the merit or the the interest of this this movement, because I think it's part of what we're trying to do. But I think, again, I would I would just ask people to be extreme, somewhat conservative in terms of what they're accepting to grow in their own bodies, basically, and to understand the risk that's really the risk are real. If you if you have physician friends, I cannot tell you how many people, how many stories I've heard. And, you know, along with the fact that all of the impurities that exist in many of the supplements that are on sale today, you know, everybody likes to bash on the FDA and the regulatory process and how hard it is. Should it be change? I think yes, I think it's too too slow, too cumbersome, too expensive and not reflective of, you know, what we can
do today in terms of targeting drug development. But it's safe. And, you know, when one person dies from the drug that's being sold by big Pharma, everybody goes up in arms. my God, how could that be? Big pharma is profiteering, but I hate to think of how many other people are potentially getting hurt from supplements that are unregulated and sold on Amazon, for example, that that's really where I think there's significant danger. And my understanding is that in general, even supplements that are of quality, quality, we don't really have clinical trials usually, right or not the gold standard of like they just it's it's it's not really the same level of science that we have in drugs. But it's actually in most supplements is zero science that's really that simple. It's only, you know, something that's been shown in mice but not not in humans. And in that sense, when you take vitamin B or vitamin D, I know the numbers go up, but how how can we know that it actually does something? Well, again, a really good example of where I think there's a problem. So, you know, everyone thinks that vitamin D levels when they're low should be corrected. The there have been many clinical trials about what happens when you reintroduce vitamin D and bring the levels back up. And and the evidence there is very complicated. I would say a significant number of these trials show absolutely no effect. and so but at the same time, there's been, you know, some and so some physicians have taken this data to say, well, it doesn't matter, you know, should not correct low vitamin D, But on the other hand, there are some significant problems with some of these clinical trials themselves, which just shows you how difficult it is to prove, you know, maybe vitamin D is just a reflection of some other process that we're not correcting. And so you really and this is how that aging field has been working for for 20 years, we find the level of something is low, we give more of it, and then we think, this is going to solve everything. Well, that low level of vitamin D, vitamin B12, DHEA, you know, the list goes on and on. Maybe it's just a symptom of some other modification that we're not targeting. So but it's so complicated. It is. That's that's the answer here. I was it makes me wonder, because I know you say like your goal is more toward health span, while maybe some of your peers talk about living to 200 and in mortality and I know you don't first of all, I would love to know why you choose to speak more modestly about what we can do. Well, the first one is, is one of intellectual honesty for me. I could go around and tell you that you're on the list of 200, and I could actually firmly believe it. The bottom line is there's absolutely no evidence for it. If you if anyone were people talking about living through 160 or 108, you can show me what is the evidence that this is going to happen. I will change my tune. I Haven't I haven't heard it. The second aspect is that almost always
when this kind of conversation is being heard, there's a commercial interest behind it. I'm trying to sell you something. Of course, you know, if Dr. Verdin comes and tells you you're going to live to 95 in good health, it looks a lot less exciting than to list 180. And here's my pill. Here's here are my vitamins. I just want people not to be naive about, you know, we call it snake oil salesman for a very good reason. Snake oil. This is a song as humanity. And and I don't want to be part of that tradition. This is what what we do is much more important and is going to be validated and can be demonstrated to people and actually expect some results with what we're proposing. And as you say, like at some point it could be that we get to the point where there is maybe there are new therapies that may allow us to even extend our current maximal lifespan, which is maybe 115 years. So, yes, it's not that it's impossible. Possible, technically. It's like right now we're not programed to live that long. But theoretically it could happen if we find some technology to make it happen. So, yes, I think you've hit it on the nail because some people have told me, well, you're too realistic, you're a killjoy, and you're not allowing people to dream this is not true, is totally not true at all. I dream all the time. I dream in the lab where we can do amazing things and we keep pushing the envelope and we have scientists at the doctor who are working on all of these models and including my labs and always trying to get to the next level. What I, what I know is not available is this for humans today. And there's no evidence. I mean, we've had billions of people living until today and maximum lifespan. Clearly, when you look at the data, very few people very, very few out of billions make it above 115. And you would expect that out of these billions of people, we would have had some who had optimized genomes. And and probably there are the ones who already had a very optimized genome. So I know short of everything that we know today, it's going to be very hard to go above 150 and 120. But and so and we will we will get there. But, you know, I cannot predict, you and I certainly not going to go around, tell you it's going to happen because I have no evidence for it. Yes. And I think that people also often don't fully understand the difference between median lifespan and maximum maximal lifespan, and that humans, as far as I know, like it's the fact that we doubled our lifespan. It's because we just we've been able to to reach our maximum lifespan that we had even when we lived half the time that long. It was the same. Yes. So we haven't changed that. So that's kind of a constant until we find something completely different to break that barrier. You're totally right. We sort of slowly we have that genetic endowment, which is how long we can live, and we know it's 115 for most human potentially for many humans. We just keep pushing within that envelope. And, you know,
beyond this, it's going to take something radically different. Genetic engineering, whatever, you know, things that we you know, we're starting to feel just see glimpses of, but we're certainly not able to do. We haven't talked about the Buck Institute yet, which is the first Biomedical Research Institute on Aging. And you're the president. Can you can you share some information about the vision of the institute and what what you focus your work on? Yes. So we were founded we were the first one to be founded. And and actually 25 years ago, we're just about to celebrate our 25th anniversary. And this was at a time when the in 1995, between 1990 and 1995 to also a papers that really redefined aging as a as a process that you could study using the tools of molecular biology make mutations, genetic engineering and so on. So that really changed the way we thought about aging. And the institute was founded at that time, frankly, by a group of incredible people who had incredible vision of what this could mean. So we're located in the in the in the hills north of San Francisco, about 30 minutes north in Marin County, which is one of the longest living county in the country. And today we have about 300 employees all focused on the biology of aging, about 24 faculty members who are directing each their groups. And historically, we're known for, you know, defining. But much of the biology about what we know about aging, not all of it, of course. You know, there are many other scientists across the world studying the same thing, but we certainly are the largest in terms of concentration of talent and people who are studying aging. We we take sort of a we don't have a unique focus, although we've worked a lot on senescence under the leadership of Judy Campisi, our colleague, who was really instrumental in defining the field. And it was certainly passed away this year. But we have novel initiatives. We just recruited Lee Hood, who is one of the fathers of the whole concept of P4 medicine, the idea that medicine is going to transform to a model, which is, you know, predictive, preventative, personalized. So And we are, you know, along with Lee and his colleagues, trying to build this new medicine of the future of the institute itself is really focused mostly on the basic biology of aging. But when I came in about seven years ago, the vision that I sold to our board was that it's time now to really bring this to medicine and to patients. And so what we've been doing is building on top of the basic infrastructure, basic science, a whole clinical infrastructure that will allow us to do clinical trials. We've actually we have five clinical trials ongoing right now using different interventions, and we're going to do a lot more in the future. But also recruiting someone like Lee was coming and helping us define what this new medicine of the future will be and the whole idea of genomic health. So these are incredibly exciting times where I think hopefully at the back we'll be able to mix the strongest basic science and the best clinical research and really change what we've been talking about all day today. This is really exciting. I would love to link to those trials. I will I will contact Lauren to get the links if it's open. And can you for for people who hear this and it might spark their interest in maybe getting involved and and maybe working in aging. What what do you say to them? Why why, why should why should we consider going that path of service? I mean, one more thing about the but we have also not only doing the research, but we have a big education mission. And I invite you, if you've never visited our website, just go back in situ dot org and you will find seminars, podcast, all kinds of information that might interest you about the aging space. And so I invite you to visit. Just sign up for our newsletter. I think I can send you the link as well. Now, if you are a young scientist or a young person or looking for something exciting to do with your life, I could not think of a more exciting field than the one that we work on everyday. You know, many, many people who work in biomedical research work on one disease, and they will start their talk by saying, well, there are 10 million people who are affected by this. Well, when you study aging, there are 8 billion people who are affected by this. And and this is as the true potential could be transformative for all of humanity. So I would say we need a lot more young people, especially in bioinformatics. Computer science is really coming huge into all of biology and we need the brightest and the best to come and help us to solve that riddle and work on this. It's truly an exciting field to be in. So I think that's something maybe that people don't know, even that, that, that even if you haven't studied biology, there are a lot of other fields that are definitely desire. Absolutely. Do you have any any anything else you would like to share. Or just just a message of hope? Because I know some people have told me, well, you're being too realistic. I said, No, I want to change the world, but I want to change it today, not in 50 years. And I can you know, of course, there's room for dreaming. There's room for having incredible audacious dreams. And I think I'd share them with everyone in the aging field. I also feel that we have a unique opportunity to change the way people are aging today. And so right now we're focusing on this. This is half of our effort. The other half is the dreaming is really pushing forward and really reinventing aging as we know it. Yes. And just for those who really want to look for ways to improve their their own ability to prevent, to make sure that they age in a better way. And since there is such a there is no real hierarchy on the Internet, at least what's what's right, what's wrong, what's helpful, what can be damaging. Do you have any tips about that? Like where should people go for resources to educate themselves on what they can do as individuals? I would say there are a number of respected people in the field Do your homework. I don't want to be sort of endorsing anyone in particular, but there are some there are some clear quacks. If someone is promising something that sounds too good to be true, it probably is. And there are some great aggregators in the field who are a podcast, news newsletter and so on. I would say listen to all of it and always go back to the question, is that person trying to sell me something? And if they are, then it's a lot more suspicious than than the person who is really trying to educate you. And there are many who actually do a very good job at both.